227Th - Oncidium Foundation

Th-227-Epratuzumab (Th-227-BAY1862864)

227Th-Epratuzumab (227Th-BAY1862864 is a CD-22 thorium conjugate targeting relapsed or [...]

support dev2022-04-25T15:06:07+00:00

227Th-Pelgifatamab(227Th-PSMA-TTC, 227Th-BAY2315497) is a Thorium-227 labelled PSMA-targeted full IgG antibody [...]

support dev2022-10-11T11:16:48+00:00

227Th-Anetumab corixetan (227Th-BAY2287411) is a mesothelin targeted thorium conjugate (MSLN-TTC) [...]

support dev2022-10-11T11:14:02+00:00